within Pharmacolibrary.Drugs.C_CardiovascularSystem.C02D_ArteriolarSmoothMuscleAgentsActingOn.C02DB02_Hydralazine;

model Hydralazine
  extends Pharmacolibrary.Drugs.ATC.C.C02DB02
  // parameters inherited from base class, duplicate, uncomment and change if necesarry
  /*
  
    weight         = 70,
    F              = 0.35,
    Cl             = 1.1083333333333331e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.0028,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001  
  */
  ;

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Hydralazine</td></tr><tr><td>ATC code:</td><td>C02DB02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>50</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.8</td><td>L</td></tr>
    <tr><td>clearance:</td><td>9.5</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Hydralazine is a vasodilator used primarily to treat hypertension and congestive heart failure. It acts by directly relaxing vascular smooth muscle, leading to decreased peripheral resistance. Hydralazine is still approved and used clinically, often as adjunct therapy or when first-line antihypertensive agents are unsuitable.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from studies in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Crawford, MH, et al., &amp; Kennedy, GT (1985). Determinants of systemic availability of oral hydralazine in heart failure. <i>Clinical pharmacology and therapeutics</i> 38(5) 538â€“543. DOI:<a href=\"https://doi.org/10.1038/clpt.1985.220\">10.1038/clpt.1985.220</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4053489/\">https://pubmed.ncbi.nlm.nih.gov/4053489</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Hydralazine;
